Helen of Troy reports mixed Q2 results; updates FY27 outlook

Helen of Troy's stock experienced a significant surge of 8.3% during pre-market trading following the release of better-than-expected second-quarter fiscal 2027 earnings. The company surpassed consensus estimates with adjusted diluted EPS at $0.79 compared to the expected $0.50. Net sales increased by 2.1% year-over-year, reaching $440.9 million.

A key factor driving the positive response was the company's decision to raise its full-year fiscal 2027 outlook, extending adjusted diluted EPS guidance to $3.60–$4.15 from the previous range of $3.25–$3.75, and enhancing free cash flow guidance to $120–$140 million from $85–$100 million. This optimistic outlook was further reinforced by an upgrade from Canaccord Genuity, which increased its price target from $25 to $26 while maintaining a Hold rating, and a Form 4 insider filing on October 7, 2026, which heightened investor interest.

CEO G. Scott Uzzell highlighted broad-based sales growth across the Home & Outdoor, Wellness, and International segments, emphasizing the company's ongoing improvements in its balance sheet and free cash flow generation. Despite broader consumer sector challenges stemming from tariff concerns and macroeconomic factors, Helen of Troy's ability to beat estimates and raise guidance proved particularly noteworthy to investors.

The confluence of a substantial EPS beat, expanding gross margins, a substantially increased free cash flow outlook, and consistent segment growth instilled confidence in investors, resulting in a sharp rise in shares and positioning the stock near the upper range of its 52-week trading band of $13.85–$30.68.